postinfarction patients who had experienced at least one episode of ventricular fibrillation or sustained ventricular tachycardia and who were studied after this event. Group 2 consisted of 14 postinfarction patients without tachyarrhythmic events after their infarct. Both groups were carefully matched with respect to age, sex, infarct location, extent of coronary artery disease, left ventricular ejection fraction, blood pressure, and heart rate at rest. Heart rate variability was assessed from 24-hour Holter recordings, and baroreflex sensitivity was determined by means of the phenylephrine method. Indices of heart rate variability were not E xperimental and clinical studies conducted dur- ing the past two decades have convincingly demonstrated that the autonomic nervous system plays a critical role in the genesis of sudden cardiac death,1-5 particularly in the presence of ischemic heart disease. Specifically, sympathetic hyperactivity promotes the occurrence of life-threatening ventricular tachyarrhythmias,4 whereas augmented vagal tone exerts a protective and antifibrillatory effect.6 Two clinically applicable methods for assessment of the cardiac autonomic control have been developed: determination of heart rate variability from short-or long-term ECG recordings7-11 and evaluation of baroreflex sensitivity according to the phenylephrine method.1213 An important distinction is that whereas heart rate variability determined from Holter recordings reflects primarily tonic vagal activity, baroreflex sensitivity indicates predominantly reflex vagal activity. Conclusions The results of this study indicate that postmyocardial infarction patients who develop life-threatening ventricular tachyarrhythmias, compared with carefully matched postinfarction patients without major arrhythmic episodes, differ strikingly in terms of baroreflex sensitivity but not in terms of heart rate variability. This finding may have implications for the risk stratification of postinfarction patients and may lead to a differential therapeutic strategy based on autonomic testing. (Circulation. 1994; 89:1068 -1073 Key Words * nervous system * heart rate * death, sudden have been proved to be useful in risk stratification after myocardial infarction.14' 15 Bigger et al'6 addressed the issue of the potential redundancy of the two tests. They compared heart rate variability and baroreflex sensitivity in 32 postinfarction patients and found that only a weak statistical correlation (r=.6) existed between the two methods; ie, one cannot be used to predict the results obtained with the other. Moreover, the relative yield of either method with respect to prediction of future arrhythmic events in patients after myocardial infarction remains to be determined.
The present study aimed to compare heart rate variability and baroreflex sensitivity measurements in two selected groups of carefully matched postinfarction patients. One group included patients who after their index infarction experienced an episode of out-of-hospital syncopal ventricular tachycardia or ventricular fibrillation, and the other group served as control subjects.
Methods

Patient Population
The study group consisted of 28 patients with coronary artery disease and a history of remote myocardial infarction that had been diagnosed by the presence of typical chest pain associated with ECG changes and elevation of creatine kinase. All patients had undergone coronary and left ventricular angiography that confirmed both the presence of coronary artery disease and regional wall motion abnormalities corresponding to the infarct location in the surface ECG. Exclusion criteria for the study were systemic arterial hypertension, insulin-dependent diabetes mellitus, atrial fibrillation, or coexisting valvular disease. At the time of baroreflex sensitivity and heart rate variability measurements, patients had to be in stable clinical condition; in particular, without any signs of uncompensated congestive heart failure or overt angina pectoris.
Patients were divided into two groups according to the history of aborted sudden cardiac death, which was present in 14 individuals (group 1). In all of these patients, at least one episode of out-of-hospital cardiac arrest due to sustained ventricular tachycardia (n=7) or ventricular fibrillation (n=7) not associated with acute myocardial infarction had been documented. These episodes of cardiac arrest occurred after a median of 43 months (range, 9 to 182 months) after the index infarction. These patients were referred to the Department of Medicine at the University Hospital in Freiburg for evaluation of antiarrhythmic management, including the implantation of an automatic cardioverter/defibrillator.
The other 14 patients (group 2) were a stratified sample from a larger group of 102 postinfarction patients with baroreflex sensitivity and heart rate variability who were studied at the same center as part of an ongoing international multicenter trial of postinfarction risk stratification (ATRAMI5). These patients were studied within 4 weeks after their myocardial infarction.
The patients in groups 1 and 2 were carefully matched, with special attention to those demographic and clinical variables that might affect the autonomic markers under study. 15 Baroreflex Sensitivity Study All patients were carefully instructed about the study, and all gave informed consent to participate. The study protocol was approved by the ethics committee of the University of Freiburg. Baroreflex sensitivity determination was performed according to the phenylephrine method.'2 The patients were placed in the supine position in a comfortable environment and were instructed to breath regularly. A slow intravenous saline infusion was started. The ECG limb leads were used to determine RR intervals, and blood pressure was measured noninvasively during the entire test (Finapres 2300 blood pressure monitor, Ohmeda, Louisville, Colo). Thirty minutes was allowed for stabilization before basal blood pressure and heart rate measurements were started. Heart rate and blood pressure were continuously displayed on an oscilloscope (Mingoscop M 8, Siemens, Erlangen, Germany) and, after analogto-digital conversion, were fed into a Siemens PCD-2 computer system and stored for subsequent analysis.
After the stabilization period, patients received a test bolus injection of phenylephrine (2 ,ug/kg) to evaluate the magnitude of the resulting increase in systolic blood pressure. (Fig 1) . Two considerations can be made in examining Fig 1. The first is that for all the three measures of heart rate variability, there is a considerable degree of overlap between groups 1 and 2. The second relates to the single patient in group 1 who had a very high value of SDNN. Without this outlier, the difference between the two groups would have reached statistical significance, but only for SDNN. Indeed, his presence or absence does not modify the lack of statistical difference for pNN50 or HF.
Baroreflex Sensitivity
In contrast to heart rate variability, baroreflex sensitivity differed significantly between the two groups. Specifically, as shown in Fig 2, To rule out the possibility of selection bias, the mean baroreflex sensitivity value of the 14 group 2 patients was compared with that of the total cohort of 102 consecutive postinfarction patients of which these patients represented a stratified sample. The total cohort of 102 patients exhibited an average baroreflex sensitivity value of 8.51 + 6.40 ms/mm Hg, indicating that the 14 patients selected represent the whole patient population evaluated by the phenylephrine test.
Clinical Considerations
For the total patient population studied, there was no significant correlation between baroreflex sensitivity and left ventricular ejection fraction (r=.27; P=NS). Patient Follow-up The 14 patients in group 1 were treated by means of an automatic implantable cardioverter/defibrillator. They were followed for 13±6 months. During this time, 9 of 14 patients (64%) received appropriate shocks from the device for treatment of ventricular fibrillation or sustained hemodynamically compromising ventricular tachycardia. The 14 group 2 patients were also followed for 13+7 months. None of these individuals experienced major arrhythmic episodes during this time period.
Discussion
The results of the present study indicate that postmyocardial infarction patients who develop a cardiac arrest, compared with carefully matched postinfarction patients who do not experience major arrhythmic episodes, differ strikingly in terms of baroreflex sensitivity but not in terms of heart rate variability. This finding may have implications for the risk stratification of postinfarction patients and may lead to a differential therapeutic strategy based on autonomic testing. Baroreflex Sensitivity and Heart Rate Variability After Myocardial Infarction After myocardial infarction, both baroreflex sensitivity and heart rate variability decrease in the majority of individuals (approximately 75% of patients).19 '20 This information can be obtained only by internal control analyses with measurements made before and after a myocardial infarction, implying that these data have to come from experimental studies. Clinically, only group comparison between patients with and without myocardial infarction can be performed. Nonetheless, there is convergent evidence721 that, within a few months after myocardial infarction, there is a progressive return of depressed baroreflex sensitivity and heart rate variability toward values similar to those present in the noninfarcted population. In some patients, however, vagal activity remains depressed for a considerable amount of time. 21 Before the present study, it was not known whether this would be associated with a greater risk for life-threatening arrhythmias.
The mechanism involved in the well-documented transient depression in vagal activity after myocardial infarction remains speculative. We favor the hypothesis that involves a cardiocardiac sympathovagal reflex. 22 The necrotic scar alters the geometry of the beating heart, resulting in an increased activity of sympathetic afferent fibers23 secondary to distortion of their sensory endings; as previously demonstrated,22 this produces an inhibition of cardiac vagal efferent activity. Indeed, it has recently been shown that the reflex increase in vagal efferent traffic secondary to a blood pressure rise (the baroreceptive reflex) is largely blunted by the presence of intact cardiac sympathetic afferents. 24 
Prognostic Value of Autonomic Markers
The first hint that analysis of autonomic reflexes might provide prognostic information came from experimental studies dealing with baroreflex sensitivity in conscious dogs. 13 Finally, another important aspect of the present study deserves comment. Although myocardial infarction had occurred in group 1 patients months to years before the occurrence of life-threatening arrhythmias, all individuals exhibited markedly depressed baroreflex sensitivity values. The fact that baroreflex sensitivity was markedly depressed in the ventricular tachycardia/ventricular fibrillation patients months after the infarct compared with the matched control subjects soon after the myocardial infarction argues that the difference might have been greater had baroreflex sensitivity been measured at a similar time after the remote infarction in the two groups. Furthermore, this indicates that failure of the baroreflexes to recover after myocardial infarction identifies patients with a persistent high risk for the development of ventricular fibrillation or syncopal ventricular tachycardia. Importantly, this implies that during follow-up, baroreflex sensitivity can be usefully determined at various times after myocardial infarction without losing its predictive power. Difference Between Barorefiex Sensitivity and Heart Rate Variability
In the present study, baroreflex sensitivity, and not heart rate variability, distinguished between postinfarction patients with and without ventricular fibrillation and ventricular tachycardia. In the absence of a definite explanation, a tenable hypothesis can be postulated.
The main difference between baroreflex sensitivity and heart rate variability is that the former informs on the capability of the autonomic nervous system to respond to a stimulus with a given increase in acetylcholine release, whereas heart rate variability informs about the level of acetylcholine released on a continuous basis, ie, tonic activity. This concept involves some degree of oversimplification, because heart rate changes reflect the sympathetic-parasympathetic interaction at the level of the sinus node, ie, the combined effects of norepinephrine and acetylcholine and not only the vagal component.
When acute myocardial ischemia occurs, there is a reflex increase in sympathetic efferent activity. 30 To counteract the arrhythmogenic31 influence of this reflex, it is necessary to increase the amount of acetylcholine released (eg, via a reflex vagal activation) over that released by tonic activity. If one assumes that a considerable portion of the life-threatening arrhythmias in the present study population might have been related to a transient ischemic episode,32 then it becomes easier to understand why it is the impairment in baroreflex sensitivity, and only to a much lesser extent that in heart rate variability, that identifies the individuals at high risk for cardiac arrest.
